Archive: Company News
— Incorporated US subsidiary & hired US VP Operations
— Preparing pre-submission meeting with US-FDA
— Received Notice of Allowance for key patent by USPTO
InfanDx AG, a privately-held diagnostics company focusing on the development and commercialization of novel diagnostic solutions for newborns, today announced that it has set up US operations to gain access to the US market for its HypoxE® Test. The test is designed for the early detection of Hypoxic-Ischemic Encephalopathy (HIE) and is currently in clinical development.